Who invested in GeneCentric Diagnostics?
GeneCentric Diagnostics's investors include Hatteras Venture Partners and Dow Jones.
United States · Series B startup
4 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$28Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
From a historical funding recordSEC filing: $5.0M sold, first sale Jun 2013
No investor was named in the report.
Reported by bizjournals.comSEC filing: $2.5M sold, first sale Jun 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
GeneCentric Diagnostics's investors include Hatteras Venture Partners and Dow Jones.
GeneCentric Diagnostics has raised $28M across 4 rounds since 2012. One round did not disclose an amount, so the total is a floor.
GeneCentric Diagnostics's most recent round was a Series B of $20M in Jan 2015.
Its most recent round, $20M in Jan 2015, is also its largest on record.
GeneCentric Diagnostics's first round on record, in Jan 2012, was backed by Hatteras Venture Partners.
GeneCentric Diagnostics's latest named round is a Series B, in Jan 2015.
GeneCentric Diagnostics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.